BIOMAT Database Logo BIOMAT Database Logo

NanoLuc Luciferase - A Multifunctional Tool for High Throughput Antibody Screening. 2016

Nicolas Boute, and Peter Lowe, and Sven Berger, and Martine Malissard, and Alain Robert, and Michael Tesar
Molecular and Cellular Biology Unit, Institut de Recherche Pierre Fabre, Centre d'Immunologie Pierre Fabre Saint-Julien-en-Genevois, France.

Based on the recent development of NanoLuc luciferase (Nluc), a small (19 kDa), highly stable, ATP independent, bioluminescent protein, an extremely robust and ultra high sensitivity screening system has been developed whereby primary hits of therapeutic antibodies and antibody fragments could be characterized and quantified without purification. This system is very versatile allowing cellular and solid phase ELISA but also homogeneous BRET based screening assays, relative affinity determinations with competition ELISA and direct Western blotting. The new Nluc protein fusion represents a "swiss army knife solution" for today and future high throughput antibody drug screenings.

UI MeSH Term Description Entries

Related Publications

Nicolas Boute, and Peter Lowe, and Sven Berger, and Martine Malissard, and Alain Robert, and Michael Tesar
Gaussia luciferase variant for high-throughput functional screening applications.
August 2009, Analytical chemistry,
Nicolas Boute, and Peter Lowe, and Sven Berger, and Martine Malissard, and Alain Robert, and Michael Tesar
Affordable luciferase reporter assay for cell-based high-throughput screening.
April 2013, Journal of biomolecular screening,
Nicolas Boute, and Peter Lowe, and Sven Berger, and Martine Malissard, and Alain Robert, and Michael Tesar
A dual luciferase multiplexed high-throughput screening platform for protein-protein interactions.
December 2003, Journal of biomolecular screening,
Nicolas Boute, and Peter Lowe, and Sven Berger, and Martine Malissard, and Alain Robert, and Michael Tesar
Quantitative High-Throughput Luciferase Screening in Identifying CAR Modulators.
January 2016, Methods in molecular biology (Clifton, N.J.),
Nicolas Boute, and Peter Lowe, and Sven Berger, and Martine Malissard, and Alain Robert, and Michael Tesar
Development and characterization of a stable luciferase dengue virus for high-throughput screening.
July 2011, Antiviral research,
Nicolas Boute, and Peter Lowe, and Sven Berger, and Martine Malissard, and Alain Robert, and Michael Tesar
Validating a firefly luciferase-based high-throughput screening assay for antimalarial drug discovery.
February 2012, Assay and drug development technologies,
Nicolas Boute, and Peter Lowe, and Sven Berger, and Martine Malissard, and Alain Robert, and Michael Tesar
High-throughput functional screening using a homemade dual-glow luciferase assay.
June 2014, Journal of visualized experiments : JoVE,
Nicolas Boute, and Peter Lowe, and Sven Berger, and Martine Malissard, and Alain Robert, and Michael Tesar
A mammalian expression system for high throughput antibody screening.
September 2013, Journal of immunological methods,
Nicolas Boute, and Peter Lowe, and Sven Berger, and Martine Malissard, and Alain Robert, and Michael Tesar
Antibody arrays for high-throughput screening of antibody-antigen interactions.
September 2000, Nature biotechnology,
Nicolas Boute, and Peter Lowe, and Sven Berger, and Martine Malissard, and Alain Robert, and Michael Tesar
A comparison of Ypet and firefly luciferase as reporter proteins for high-throughput screening.
January 2013, Bioscience, biotechnology, and biochemistry,
Copied contents to your clipboard!